FLoRA Replication Atlas › Browse

Midnolin is a novel regulator of parkin expression and is associated with Parkinson's Disease

Yutaro Obara, Toru Imai, Hidenori Sato, Yuji Takeda, Takeo Kato, Kuniaki Ishii

Scientific Reports, 2017. DOI 10.1038/s41598-017-05456-0

Has this study been replicated?

The atlas records 1 replication of this study. Recorded outcomes: 1 successful. The earliest on record is from 2019.

Replications

• Midnolin is a confirmed genetic risk factor for Parkinson's disease, Obara et al. (2019). Annals of Clinical and Translational Neurology. Outcome recorded: successful. We showed the strong genetic association of MIDN with PD development in a British population and in a Japanese population, suggesting MIDN is a confirmed and universal genetic risk factor for PD. Outcome read from the abstract. View paper

Cite this record

Obara, Y., Imai, T., Sato, H., Takeda, Y., Kato, T., & Ishii, K. (2017). Midnolin is a novel regulator of parkin expression and is associated with Parkinson's Disease. Scientific Reports, 7(1). https://doi.org/10.1038/s41598-017-05456-0

Other studies in the atlas

• Genome-wide association study identifies common variants at four loci as genetic risk…
• Replication Study and Meta-Analysis of Human Nonobstructive Azoospermia in Japanese…
• A Genome-Wide Association Study Identifies Five Novel Genetic Markers for…
• Replication Study for the Association of Five SNPs Identified by GWAS and…
• Do Get-Out-the-Vote Calls Reduce Turnout? The Importance of Statistical Methods for…
• Gene-Environment Interaction in Youth Depression: Replication of the 5-HTTLPR Moderation…

Failed replications · Successful replications · All browse pages